))
AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery
Manage episode 479940389 series 3642779
Content provided by TechDaily.ai. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TechDaily.ai or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Discover how AI and biotech are joining forces to transform drug development—from genomics and CRISPR target validation to machine learning–driven compound design and high-throughput screening. In this episode of TechDaily.AI (brought to you by StoneFly), we cover:
- Omics Insights: Mining genomics, transcriptomics, proteomics & metabolomics to pinpoint targets
- Gene Editing: Using CRISPR and CAR-T engineering for precision therapies
- AI in Drug Design: Leveraging ML/DL for toxicity prediction, ADME modeling & de novo molecule generation
- Automation & Scale: High-throughput assays, synthetic biology platforms (e.g., engineered yeast)
- Clinical Acceleration: AI-powered patient matching for faster trials
- Roadmap & Challenges: Data quality, explainable AI, vendor collaboration & regulatory readiness
Tune in to learn how this synergy is cutting R&D costs, speeding timelines, and paving the way for personalized medicine.
235 episodes
Share
